FEB 02, 2016 1:24 PM PST

New DNA "Aptamer" Modifications for Disease Detection and Drug Delivery

WRITTEN BY: Kara Marker
Single-stranded molecules of DNA called “aptamers” have been studied since 1990 for their ability to bind and inhibit molecular targets, a useful behavior for disease detection and drug delivery (Nature). However, aptamers have not been approved for clinical use yet because of variable binding ability and quick digestion by enzymes. With two modifications, though, a team of researchers at the Institute of Bioengineering and Nanotechnology (IBN) at the Agency for Science, Technology and Research (A*STAR), could soon be on the way to developing the first approved aptamer technology.
 
Just like the antibodies produced by the immune system that target foreign pathogens, aptamers have the potential to become a specialized army for infectious diseases. However, just like medicine, aptamers need time in the bloodstream to find and bind to their target. If they are quickly and easily digested by enzymes waiting in the blood stream, the aptamers will not have time to act, making their effectiveness irrelevant.
 

IBN Principal Research Scientist and Team Leader Dr. Ichiro Hirao and a team of researchers from A*STAR equipped their aptamers with a sequence of DNA called a “mini hairpin DNA” to prevent enzyme digestion, allowing the aptamers time to find and inhibit their targets. With the mini hairpin DNA, aptamers can survive for days rather than hours, as the DNA sequence acts as a “protective shield.”
 
Hirao’s team also overcame the problem of aptamer binding capabilities by adding an “unnatural base” that improved binding by 100 percent. Unnatural bases were developed to supplement the natural bases – A, T, G, and C (Nature). In this case, the extra component of the single-strand of DNA greatly enhanced its binding capabilities.
 
We hope to use our DNA aptamers as the platform technology for diagnostics and new drug development," said IBN Executive Director Professor Jackie Y. Ying. Scientists from the IBN plan to soon begin testing the aptamers for specific diseases. Their current study is published in the journal Scientific Reports.
 

Source: A*STAR
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 09, 2020
Genetics & Genomics
JAN 09, 2020
Exploring the Genetic Link to Parental Neglect
Early life experiences impact how the brain is formed, and creates either a stable, solid foundation for later life, or a fragile architecture....
FEB 03, 2020
Cell & Molecular Biology
FEB 03, 2020
Brain Organoids May Not be Living Up to the Hype
Cells can be grown in special ways to create three-dimensional, miniature models of organs. But how good are they?...
FEB 17, 2020
Genetics & Genomics
FEB 17, 2020
Engineering a Genome
Scientists are learning more about how to use the genetic code to make a synthetic genome with specific biological functions....
FEB 17, 2020
Cancer
FEB 17, 2020
Listening in on cancer cells
Research published today in Nature Methods reports a new technique of “listening” to cancer cells. While it may sound odd (no pun intended...
FEB 22, 2020
Genetics & Genomics
FEB 22, 2020
Evidence of Resistance to White-Nose Syndrome Appears in Some Bats
A small new study suggests that some bats might be able to resist a devastating fungal disease called white nose syndrome that has destroyed many bat populations....
MAR 16, 2020
Genetics & Genomics
MAR 16, 2020
How the Genetic Material in Sperm is Unpacked During Fertilization
The genetic material from a sperm and an egg merges to form a new human genome, and now we know more details about the process....
Loading Comments...